Cohort (CHRT) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
16 Nov, 2025Executive summary
Achieved record revenue of £270.0m, up 33% year-over-year, and record adjusted operating profit of £27.5m, up 30%, with adjusted EPS rising 27% to 54.44p, all ahead of expectations.
Order book reached a record £616.4m, providing strong visibility out to 2037 and covering 79% of expected revenue for the coming year.
Robust operating cash flow of £51.2m and net funds of £5.3m at year-end, despite acquisitions and CapEx.
Board declared a final dividend of £0.1105, bringing the total dividend to £0.163 (16.30p), a 10% increase year-over-year and the fifth consecutive annual increase.
Achieved record operating profit, revenue, and closing order book, reflecting strong business momentum and successful execution of strategy.
Financial highlights
Revenue grew 33% to £270.0m, adjusted operating profit increased 30% to £27.5m, and adjusted EPS rose 27% to 54.44p.
Operating cash flow more than doubled to £51.2m, supporting a positive net cash position.
Net margin slightly declined from 10.4% to 10.2% due to revenue mix, but is expected to rebound above 11% next year.
Sensors and Effectors division revenue up over 20% to £145.1m, with SEA achieving record performance and ELAC improving revenue and margins.
Communications and Intelligence division revenue grew 50% to £124.9m, with a 65% increase in adjusted operating profit, driven by MCL and EM Solutions.
Outlook and guidance
Strong order book underpins revenue for 2025/26, with over 90% cover in Sensors and Effectors.
Net margin for Sensors and Effectors expected to recover to 11% as SEA's mix improves and Chess recovers.
Full-year contribution from EM Solutions anticipated to drive higher revenue and margins in Communications and Intelligence.
Adjusted EPS for 2025 and 2026 now expected to be ahead of previous guidance.
Strong demand outlook driven by increased global defense spending and robust pipelines across divisions, especially in NATO and Asia-Pacific markets.
Latest events from Cohort
- Record revenue and order book, strong global demand, and robust outlook drive confidence.CHRT
Investor Update3 Feb 2026 - Record results, robust order book, and strong demand support a positive growth outlook.CHRT
H2 20243 Feb 2026 - Acquisition brings new tech, global reach, and strong financial upside in defense markets.CHRT
M&A Announcement13 Jan 2026 - Record revenue, strong order book, and global demand drive positive outlook and margin growth.CHRT
Investor Update12 Jan 2026 - Record revenue, profit, and order book set strong foundation for continued growth.CHRT
H1 202511 Jan 2026 - Revenue up 9% to £128.8m, strong order book, and positive outlook for H2.CHRT
H1 202611 Dec 2025 - Record revenue and profit growth, strong order book, and higher dividend signal robust outlook.CHRT
H2 2025 Pre-Recorded16 Nov 2025 - Record order book and strong growth position Cohort for continued expansion in defence markets.CHRT
Trading Update6 Jun 2025